» Articles » PMID: 29776801

Determinants of a Good Perinatal Outcome in 588 pregnancies in Women with Type 1 Diabetes

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2018 May 20
PMID 29776801
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This study assessed pregnancy outcomes in women with type 1 diabetes (T1D) over the last 15 years and identified modifiable factors associated with good perinatal outcomes.

Methods: Pregnancy outcomes were prospectively assessed in this cohort study of 588 singleton pregnancies (441 women) managed by standardized care from 2000 to 2014. A good perinatal outcome was defined as the uncomplicated delivery of a normally formed, non-macrosomic, full-term infant with no neonatal morbidity. Factors associated with good perinatal outcomes were identified by logistic regression.

Results: The rate of severe congenital malformations was 1.5%, and 0.7% for perinatal mortality. The most frequent perinatal complications were macrosomia (41%), preterm delivery (16%) and neonatal hypoglycaemia (11%). Shoulder dystocia occurred in 2.6% of cases, but without sequelae. Perinatal outcomes were good in 254 (44%) pregnancies, and were associated with lower maternal HbA values at delivery [adjusted odds ratio (aOR): 2.78, 95% CI: 2.04-3.70, for each 1% (11mmol/mol) absolute decrease], lower gestational weight gains (aOR: 1.06, 95% CI: 1.02-1.10) and absence of preeclampsia (aOR: 2.63, 95% CI: 1.09-6.25). The relationship between HbA at delivery and a good perinatal outcome was continuous, with no discrimination threshold.

Conclusion: In our study, rates of severe congenital malformations and perinatal mortality were similar to those of the general population. Less severe complications, mainly macrosomia and late preterm delivery, persisted. Also, our study identified modifiable risk factors that could be targeted to further improve the prognosis of pregnancy in T1D.

Citing Articles

Prepregnancy body mass index and glycated albumin in the third trimester may predict infant complications in gestational diabetes mellitus: a retrospective cohort study.

Sugawara D, Makita E, Matsuura M, Sato H, Kuwata T, Ichihashi K Diabetol Int. 2023; 14(3):280-287.

PMID: 37397905 PMC: 10307751. DOI: 10.1007/s13340-023-00631-3.


Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study.

Ogassavara J, Dualib P, Mattar R, Dib S, de Almeida-Pititto B Arch Endocrinol Metab. 2023; 67(6):e220483.

PMID: 37364140 PMC: 10660998. DOI: 10.20945/2359-4292-2022-0483.


Flash glucose monitoring system in special situations.

Rigon F, Ronsoni M, Daher Vianna A, Schiavon L, Hohl A, van de Sande-Lee S Arch Endocrinol Metab. 2022; 66(6):883-894.

PMID: 35657123 PMC: 10118756. DOI: 10.20945/2359-3997000000479.


Association Between HbA1c Levels on Adverse Pregnancy Outcomes During Pregnancy in Patients With Type 1 Diabetes.

Lemaitre M, Ternynck C, Bourry J, Baudoux F, Subtil D, Vambergue A J Clin Endocrinol Metab. 2021; 107(3):e1117-e1125.

PMID: 34694409 PMC: 8852207. DOI: 10.1210/clinem/dgab769.


Predictors of a successful vaginal delivery in women with type 1 diabetes: a retrospective analysis of 20 years.

Weschenfelder F, Herrmann E, Lehmann T, Schleussner E, Kloos C, Battfeld W Arch Gynecol Obstet. 2021; 305(6):1445-1452.

PMID: 34559296 PMC: 9166876. DOI: 10.1007/s00404-021-06255-9.